Ksenia Kuleshova for STAT CAR-T therapy, in which a patient’s own T cells are engineered to recognize and wipe out disease-causing cells, has completely changed how some cancers are treated in recent years. But in 2021, German researcher Georg Schett and his team were able to use CAR-T therapy to seemingly eradicate a young woman’s...
Tag: <span>CAR T approach</span>
Post
New CAR T approach minimizes resistance, helps avoid relapse in non-Hodgkin’s B-cell lymphoma
UNIVERSITY OF CALIFORNIA – LOS ANGELES HEALTH SCIENCES LOS ANGELES — Early results from a new, pioneering chimeric antigen receptor (CAR) T cell immunotherapy trial led by researchers at the UCLA Jonsson Comprehensive Cancer Center found using a bilateral attack instead of the conventional single-target approach helps minimizes treatment resistance, resulting in long-lasting remission for people with...